Table 4 AST profile per bacteria (non-Enterobacterales Gram-negative Bacilli)
A/Haemophilus influenzae/Haemophilus sp. | COVID + (n; %) | COVID- (n; %) | p-value | |
|---|---|---|---|---|
β-lactam (n = 31–33) | Penicillinase (n = 6–7) | 6 (25.0)/7 (26.9) | 0 (0)/0 (0) | –/– |
BLNAR (n = 3–3) | 2 (8.3)/2 (7.7) | 1 (33.3)/1 (33.3) | –/– | |
Quinolones (n = 30–32) | Resistant (n = 0–0) | 0 (0)/0 (0) | 0 (0)/0 (0) | –/– |
Rifampicin (n = 17–17) | Resistant (n = 0–0) | 0 (0)/0 (0) | 0 (0)/0 (0) | –/– |
Cotrimoxazole (n = 19–23) | Resistant (n = 11–12) | 6 (26.1)/7 (28.0) | 5 (62.5)/5 (62.5) | –a/– |
B/Pseudomonas aeruginosa/Pseudomonas sp. | COVID + (n; %) | COVID- (n; %) | p-value | |
|---|---|---|---|---|
β-lactam (n = 161–165) | Carbapenem-resistant (n = 3–3) | 1 (0.8)/1 (0.7) | 2 (11.1)/2 (11.1) | < 0.05/ < 0.05 |
Aminoglycosides (n = 158–161) | Aminoglycosides-resistant (n = 12–12) | 9 (6.4)/9 (6.4) | 3 (17.7)/3 (17.7) | < 0.05/ < 0.05 |
Quinolones (n = 155–158) | Resistant (n = 25–25) | 10 (7.1)/10 (7.0) | 15 (53.6)/15 (53.6) | < 0.05/ < 0.05 |
C/Stenotrophomonas maltophilia | COVID + (n; %) | COVID- (n; %) | p-value | |
|---|---|---|---|---|
β-lactam (n = 25) | CAZ-Resistant (n = 18) | 15 (71.4) | 3 (75.0) | – |
Quinolones (n = 42) | Resistant (n = 0) | 0 (0) | 0 (0) | – |
Cotrimoxazole (n = 41) | Resistant (n = 0) | 0 (0) | 0 (0) | – |